Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Peptide Wikipedia - Exploring Peptides

Search by peptide Name Most Popular Peptides AOD9604 BPC-157 CJC 1295 (mod GRF 1-29) Dihexa DSIP Epithalon GHK-Cu IGF-1 LR3 Ipamorelin KPV Melanotan II MK-677 (Ibutamoren) MOTS-c NAD+ Oxytocin P21 PT-141 Retatrutide Selank Semaglutide Semax Sermorelin SS-31 Su

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Search by peptide Name

Most Popular Peptides

AOD9604

BPC-157

CJC 1295 (mod GRF 1-29)

Dihexa

DSIP

Epithalon

GHK-Cu

IGF-1 LR3

Ipamorelin

KPV

Melanotan II

MK-677 (Ibutamoren)

MOTS-c

NAD+

Oxytocin

P21

PT-141

Retatrutide

Selank

Semaglutide

Semax

Sermorelin

SS-31

Survodutide

TB-500

Tesamorelin

Tesofensine

Thymalin

Thymosin Alpha-1

Tirzepatide

VIP

The full peptide list

A

ACTH

Adamax

Adipotide

AICAR

Amylin

AOD9604

ARA 290

Argireline

B

B7-33

BPC-157

Bradykinin

Bronchogen

C

Calcitonin

Cardiogen

Cartalax

Cerebrolysin

CGRP

Cholecystokinin

Chonluten

CJC 1295 (mod GRF 1-29)

CJC-1295 with DAC

Cortagen

Cortexin

D

Dihexa

DSIP

E

Epithalon

Exendin-4

F

Follistatin 344

Follistatin-315

FOXO4-DRI

G

Gastrin

GDF-11

GHK Basic

GHK-Cu

GHRP-2

GLOW

GLP-1

Glucagon

Glutathione

GnRH

Gonadorelin

H

Hexarelin

HGH Frag 176-191

Humanin

I

Ibutamoren

IGF-1

IGF-1 LR3

Ipamorelin

K

Kisspeptin-10

KLOW

KPV

L

Leu-Enkephalin

Liraglutide

Livagen

LL-37

M

Melanotan II

Met-Enkephalin

MK-677 (Ibutamoren)

MOTS-c

MSH

N

NAD+

Neuromedin U

Neuropeptide Y

O

Ovagen

Oxytocin

P

P21

Palmitoyl Oligopeptide

Palmitoyl Tetrapeptide-7

Palmitoyl Tripeptide-3

Pancragen

Parathyroid Hormone

PE-22-28

PEG-MGF (Pegylated Mechano Growth Factor)

Peptide YY

Pinealon

PNC-27

Prostamax

PT-141

R

Retatrutide

S

Selank

Semaglutide

Semax

Sermorelin

Somatostatin

SS-31

Substance P

Survodutide

T

TB-500

Teriparatide

Tesamorelin

Tesofensine

Testagen

Tetracosactide

Thymagen

Thymalin

Thymosin Alpha-1

Tirzepatide

TRH

Triptorelin

U

Uroguanylin

V

Vasopressin

Vesilute

Vesugen

Vilon

VIP

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Neuroprotection in Neurodegenerative Research

P21 is extensively studied for its ability to shield neurons from damage in models of neurodegenerative disorders such as Alzheimer’s and Parkinson’s. It promotes neuronal survival and function, making it a candidate for exploring treatments aimed at slowing disease progression.

Source: exploring-peptides.com ↗

Anti-Aging and Longevity Studies

The peptide is a significant focus in longevity research due to its ability to reduce senescent cell burden, which is linked to aging phenotypes. In animal models, FOXO4-DRI has shown potential to improve healthspan by restoring organ function and reducing age-related inflammation.

Source: exploring-peptides.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosages

Tetracosactide is administered via intramuscular or intravenous injection for diagnostic and therapeutic purposes in clinical settings. For diagnostic use a standard dose of 250 micrograms (mcg) is typically given as a single injection, with cortisol levels measured 30 to 60 minutes later to evaluate adrenal response. In therapeutic applications, such as managing infantile spasms or inflammatory conditions like multiple sclerosis flares or rheumatoid arthritis, doses vary based on patient needs. For adults, therapeutic doses typically range from 0.25-1 mg daily, administered intramuscularly, often for 3 to 5 days. In pediatric patients with infantile spasms, dosing is weight-based, commonly 20 to 40 mcg per kilogram per day, given intramuscularly over a 2- to 4-week course, with gradual tapering. The peptide is prepared by dissolving the lyophilized powder in sterile saline, ensuring proper administration. Dosing regimens are tailored to users’ conditions, with medical supervision guiding adjustments to achieve optimal outcomes.

Source: exploring-peptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →